Dexamethasone and Omniscan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexamethasone (dexamethasone) and Omniscan (gadodiamide). Common drug interactions include fluid retention among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Dexamethasone and Omniscan. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.

On Aug, 06, 2026

57 people who take Dexamethasone and Omniscan together, and have interactions are studied.

Dexamethasone and Omniscan drug interactions.

What are the common drug interactions of Dexamethasone and Omniscan, by gender? *:

female:

Fluid retention (an abnormal accumulation of fluid in the blood)
Hyperkeratosis (thickening of the outer layer of the skin)
Impaired healing
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pneumonia
Pruritus (severe itching of the skin)
Skin atrophy (wasting of skin)
Skin hypopigmentation (loss of skin colour)
Skin ulcer
Arthralgia (joint pain)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Mobility decreased (ability to move is reduced)
Skin induration (an abnormally hard spot or area on the skin)
Rash
Skin fibrosis (fibrous tissue formation on skin)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Subcutaneous nodule

What are the common drug interactions of Dexamethasone and Omniscan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Cardiac arrest
Pain in extremity
Joint contracture (a permanent shortening of a muscle or joint)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
Mobility decreased (ability to move is reduced)
Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Skin induration (an abnormally hard spot or area on the skin)

20-29:

n/a

30-39:

Deformity (disfigurement)
Device related infection
Erythema (redness of the skin)
Muscle tightness
Muscular weakness (muscle weakness)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Pain
Pain in extremity

40-49:

Pain of skin
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin plaque (red, scaly patches to appear on the skin)
Skin tightness
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

50-59:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Erythema (redness of the skin)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Mobility decreased (ability to move is reduced)
Oedema peripheral (superficial swelling)
Skin exfoliation (removal of the oldest dead skin cells)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Skin hypopigmentation (loss of skin colour)
Skin induration (an abnormally hard spot or area on the skin)
Skin plaque (red, scaly patches to appear on the skin)
Dysuria (painful or difficult urination)
Muscular weakness (muscle weakness)
Renal failure chronic (long lasting kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 30 people, 52.63%
Pain: 18 people, 31.58%
Nuclear Magnetic Resonance Imaging Abdominal: 14 people, 24.56%
High Blood Cholesterol: 12 people, 21.05%
Herpes Zoster: 12 people, 21.05%
Depression: 12 people, 21.05%
Device Related Infection: 12 people, 21.05%
Nausea (feeling of having an urge to vomit): 12 people, 21.05%
Itching: 12 people, 21.05%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and Omniscan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously